Health & Environmental Research Online (HERO)


Print Feedback Export to File
656693 
Journal Article 
Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions 
McCarty, KM; Smith, TJ; Zhou, W; Gonzalez, E; Quamruzzaman, Q; Rahman, M; Mahiuddin, G; Ryan, L; Su, L; Christiani, DC 
2007 
Yes 
Carcinogenesis
ISSN: 0143-3334
EISSN: 1460-2180 
28 
1697-1702 
English 
BACKGROUND: Single-nucleotide polymorphisms in genes related to DNA repair capacity and ultraviolet exposure have not been well investigated in relation to skin lesions associated with arsenic exposure. This population based case-control study, of 600 cases and 600 controls, frequency matched on age and gender in Pabna, Bangladesh, in 2001-2002, investigated the association and potential effect modification between polymorphisms in Xeroderma Pigmentosum complementation group D (XPD) (Lys751Gln and Asp312Asn) genes, tendency to sunburn and arsenic-related skin lesions. METHODS: Unconditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). RESULT: No significant association was observed between skin lesions and the XPD 312 Asp/Asn (adjusted OR = 0.87, 95% CI = 0.65-1.15) Asn/Asn (adjusted OR = 0.76, 95% CI = 0.50-1.15) (referent Asp/Asp); XPD 751 Lys/Gln (adjusted OR = 0.92, 95% CI = 0.69-1.23) Gln/Gln (adjusted OR = 0.98, 95% CI = 0.66-1.45) (referent Lys/Lys). While we did not observe any evidence of effect modification of these polymorphisms on the association between well arsenic concentration and skin lesions, we did observe effect modification between these polymorphisms and sunburn tendency and arsenic-related skin lesions. Individuals with the heterozygote or homozygote variant forms (Asp/Asn or Asn/Asn) had half the risk of skin lesions (OR = 0.45, 95% CI = 0.29-0.68) compared with those with the wild-type XPDAsp312Asn genotype (Asp/Asp) and individuals with heterozygote or homozygote variant forms (Lys/Gln or Gln/Gln) had half the risk of skin lesions (OR = 0.47, 95% CI = 0.31-0.72) compared with those with the wild-type XPDLys751Gln genotype (Lys/Lys), within the least sensitive strata of sunburn severity. We observed effect modification on the multiplicative scale for XPD 751 and XPD 312. CONCLUSION: XPD polymorphisms modified the relationship between tendency to sunburn and skin lesions in an arsenic exposed population. Further study is necessary to explore the effect of XPD polymorphisms and sun exposure on risk of arsenic-related skin lesions. 
Adult: Amino Acid Substitution/*genetics: Arsenic/*adverse effects/analysis: Asparagine/genetics: Aspartic Acid/genetics: Case-Control Studies: Female: Genetic Predisposition to Disease: Glutamine/genetics: Humans: Lysine/genetics: Male: *Polymorphism, Single Nucleotide: Skin Diseases/chemically induced/*genetics: Sunburn/*genetics: Water Supply/analysis: Xeroderma Pigmentosum Group D Protein/*genetics 
• Arsenic Hazard ID
     1. Initial Lit Search
          PubMed
          WOS
          ToxNet
     4. Considered through Oct 2015
     7. Other Studies through Oct 2015
          Susceptibility
          Susceptibility Category
               Genetic Polymorphisms
• Arsenic (Inorganic)
     1. Literature
          PubMed
          Toxline, TSCATS, & DART
          Web of Science
          Identified during manual review of authoritative sources
     3. Hazard ID Screening
          Other potentially supporting studies
     5. Susceptibility Screening
          Relevant
               Human
• Arsenic Susceptibility
     4. Susceptibility and Lifestages
          Genetic polymorphisms
     5. Health Effect
          Skin Diseases
     1. Susceptibility Literature Screening
          Supplemental Search
          Health Effect Screening: Susceptibility
     Life Stages Citation Mapping
          Top 5%